Publications

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.

Drury RE. et al, (2024), Nat Commun, 15

Typhoid conjugate vaccines: a step towards typhoid control

Shakya M. and Pollard AJ., (2024), The Lancet Global Health, 12, e535 - e536

Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

Lin G-L. et al, (2024), Nature Communications, 15

Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection.

Chappin K. et al, (2024), The Journal of infectious diseases, 229, S100 - S111

Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study.

Ashton PM. et al, (2024), The Lancet. Microbe, 5, e226 - e234

Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study.

Schlapbach LJ. et al, (2024), The Lancet. Child & adolescent health

Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis.

Deng S. et al, (2024), The Journal of infectious diseases, 229, S25 - S33

Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.

Ng M. et al, (2024), The Journal of infection

Respiratory Syncytial Virus-Associated Hospital Admissions by Deprivation Levels Among Children and Adults in Scotland.

Osei-Yeboah R. et al, (2024), The Journal of infectious diseases, 229, S61 - S69

Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.

Osei-Yeboah R. et al, (2024), The Journal of infectious diseases, 229, S70 - S77

Underreporting and Misclassification of Respiratory Syncytial Virus-Coded Hospitalization Among Adults in Denmark Between 2015-2016 and 2017-2018.

Egeskov-Cavling AM. et al, (2024), The Journal of infectious diseases, 229, S78 - S83

Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial

Williams LR. et al, (2024)

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study

Puri A. et al, (2024), Vaccines, 12, 210 - 210

AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study.

Meeraus W. et al, (2024), The Journal of infection

Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK.

Smith C. et al, (2024), BMJ open, 14

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial

Kulkarni PS. et al, (2024), The Lancet

Spotlight on systems vaccinology: a novel approach to elucidate correlates of protection.

Zhu H. et al, (2023), Genes Immun

Typhoid fever.

Meiring JE. et al, (2023), Nat Rev Dis Primers, 9

The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public.

Kantor J. et al, (2023), BMJ Open, 13

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.

Thomas TM. et al, (2023), Human vaccines & immunotherapeutics, 19

Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort.

Hanumunthadu B. et al, (2023), BMJ Open, 13

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.

Hill M. et al, (2023), BMJ Open, 13

A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study

Jackson HR. et al, (2023), The Lancet. Digital health, 5, e774 - e785

Raising AWaRe-ness of antimicrobial stewardship challenges in pediatric emergency care: results from the PERFORM study assessing consistency and appropriateness of antibiotic prescribing across Europe.

Kolberg L. et al, (2023), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Early transcriptional responses to human enteric fever challenge

Barton A. et al, (2023), Infection and Immunity

External validation of the discriminative validity of the ReSVinet score & development of simplified ReSVinet scores in secondary care.

Sheikh Z. et al, (2023), The Journal of infectious diseases

Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes.

Carey ME. et al, (2023), eLife, 12

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland.

Ramasamy MN. et al, (2023), The Lancet. Microbe

Motivations for paediatric vaccine trial participation.

Hillson K. et al, (2023), Trials, 24

Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study

Shah P. et al, (2023), The Lancet Regional Health - Europe, 32

The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis

Aguilar GR. et al, (2023), The Lancet Regional Health - Americas, 25, 100561 - 100561

Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature

Habgood-Coote D. et al, (2023), Med

External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised children.

Martin AJ. et al, (2023), Archives of disease in childhood

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.

Costa Clemens SA. et al, (2023), Human vaccines & immunotherapeutics, 19

Impact of infection on proteome-wide glycosylation revealed by distinct signatures for bacterial and viral pathogens.

Willems E. et al, (2023), iScience, 26

Molecular correlates of vaccine-induced protection against typhoid fever

Zhu H. et al, (2023), Journal of Clinical Investigation

Biobanking and consenting to research: a qualitative thematic analysis of young people's perspectives in the North East of England.

van der Velden FJS. et al, (2023), BMC medical ethics, 24

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q.

Niewold P. et al, (2023), Scientific reports, 13

Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data

Feng S. et al, (2023), eClinicalMedicine, 61, 102073 - 102073

Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.

Kazmin D. et al, (2023), NPJ vaccines, 8

Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trials.

Kelly S. et al, (2023), Trials, 24

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

Dold C. et al, (2023), Science translational medicine, 15

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.

Kaplonek P. et al, (2023), Nature immunology

Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature.

Jackson HR. et al, (2023), Journal of the Pediatric Infectious Diseases Society, 12, 322 - 331

Emergency medical services utilisation among febrile children attending emergency departments across Europe: an observational multicentre study.

Tan CD. et al, (2023), European journal of pediatrics

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.

McCann N. et al, (2023), BMJ open, 13

Adeno-associated virus 2 infection in children with non-A-E hepatitis.

Ho A. et al, (2023), Nature, 617, 555 - 563

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).

Koen AL. et al, (2023), Vaccine, 41, 3486 - 3492

Genomic investigations of unexplained acute hepatitis in children.

Morfopoulou S. et al, (2023), Nature, 617, 564 - 573

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.

Dold C. et al, (2023), Vaccine, 41, 3047 - 3057

Cookies on this website

Publications